Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tamiflu Developer Calls Hong Kong Tamiflu Restriction ‘Stupid’

This article was originally published in PharmAsia News

Executive Summary

A scientist who helped develop Roche Holding's Tamiflu (oseltamivir phosphate) drug says the effort by Hong Kong authorities to restrict dispensing of the drug during a recent flu outbreak was stupid. Authorities advised physicians to limit the drug to patients suffering complications, fearing overuse could cause resistance. Graeme Laver, a professor who helped develop the drug, said the virus on which Tamiflu is based will not mutate into a resistant variety and urged it be given on a non-prescription basis. (Click here for more



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts